title: Ramipril treatment in a patient with glycogen storage disease I non-A.
abstract: We studied the effect of ramipril on proteinuria and mild hypertension in a 21-year-old patient affected by glycogen storage disease type I non-A. After few months of therapy we obtained a decrease in total urine protein excretion that later re-increased in spite of the high dose of ACE inhibitor. Even if ACE inhibitors are the only effective therapy for GSD I nephropathy, further studies are requested.
authors.affiliation: Department of Pediatrics, University of Milan, San Paolo Hospital, Milan, Italy. marialorella.gianni@tin.it
authors.forename: M L
authors.initials: ML
authors.lastname: Giannì
authors.forename: M
authors.initials: M
authors.lastname: Bonvissuto
authors.forename: M
authors.initials: M
authors.lastname: Gallieni
authors.forename: C
authors.initials: C
authors.lastname: Testolin
authors.forename: E
authors.initials: E
authors.lastname: Racchi
authors.forename: E
authors.initials: E
authors.lastname: Riva
mesh_terms: D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D005952:Glucose-6-Phosphatase / Q000235:genetics; D005953:Glycogen Storage Disease Type I / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy / Q000235:genetics; D007674:Kidney Diseases / Q000188:drug therapy / Q000235:genetics; D008297:Male; D011507:Proteinuria / Q000150:complications; D017257:Ramipril / Q000627:therapeutic use*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D005952:Glucose-6-Phosphatase; D017257:Ramipril